RPRX Financial Facts
Interest income: 10KResearch and development: 3.18M
See Full Income Statement
Fixed assets, net: 4K
Total stockholders' equity: 8.36M
See Full Balance Sheet
Repros Therapeutics Inc. (RPRX) Earnings
|
Expand Research on RPRX
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -46.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | $1.28 | N/A | N/A | $789.52M | N/A | N/A | N/A | ||
| 5/6/26 |
Q126 | N/A | $1.12 | N/A | N/A | $906.01M | N/A | N/A | N/A | ||
| 2/11/26 | Q425 | $0.00 | N/A | N/A | $622M | $796.14M | N/A |  | | Details | |
| 11/5/25 |
Q325 | N/A | $0.99 | N/A | N/A | $734.92M | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | N/A | $1.04 | N/A | N/A | $696.29M | N/A | N/A | N/A | ||
| 5/8/25 |
Q125 | N/A | $1.07 | N/A | N/A | $727.67M | N/A | N/A | N/A | ||
| 2/11/25 | Q424 | $0.00 | N/A | N/A | $594M | $596M | N/A | | | Details | |
| 11/6/24 |
Q324 | N/A | $0.93 | N/A | N/A | $696.92M | N/A | N/A | N/A |
